DOI QR코드

DOI QR Code

Female Breast Cancer Incidence and Mortality in Mexico, 2000-2010

  • Anaya-Ruiz, Maricruz (Laboratory of Cellular Biology, Centro de Investigacion Biomedica de Oriente, Instituto Mexicano del Seguro Social) ;
  • Vallejo-Ruiz, Veronica (Laboratory of Molecular Biology, Centro de Investigacion Biomedica de Oriente, Instituto Mexicano del Seguro Social) ;
  • Flores-Mendoza, Lilian (Laboratory of Immunology, Centro de Investigacion Biomedica de Oriente, Instituto Mexicano del Seguro Social) ;
  • Perez-Santos, Martin (Vice-rectory of Research and Postgraduate Studies, Benemerita Universidad Autonoma de Puebla)
  • Published : 2014.02.01

Abstract

The objective of this study was to investigate the recent incidence and mortality trends for breast cancer in Mexican females. Data between 2000 and 2010 from the Department of Epidemiology of the Ministry of Health, and International Agency for Research on Cancer (IARC) were analyzed. Age-standardized rates (ASRs) and annual percent changes (APCs) were calculated. The absolute incidence and mortality rates of breast cancer increased: 3,726 and 4,615 in 2000 to 8,545 and 4,966 in 2010, respectively. Incidence increased over time in all age groups tested, the 60-64 age group had the highest ASR (57.4 per 100,000 women in 2010), while the 20-44 age group had the lowest ASR (12.3 in 2010). The results show that incidence of breast cancer has increased in Mexico during last one decade, especially among older women, while the downturn observed in mortality mainly reflects improved survival as a result of earlier diagnosis and better cancer treatment.

Keywords

References

  1. Alegre MM, Knowles MH, Robison RA, et al (2013). Mechanics behind breast cancer prevention - focus on obesity, exercise and dietary fat. Asian Pac J Cancer Prev, 14, 2207-12. https://doi.org/10.7314/APJCP.2013.14.4.2207
  2. Anderson BO, Yip CH, Smith RA, et al (2008). Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the Breast Health Global Initiative Global Summit 2007. Cancer, 113, 2221-43. https://doi.org/10.1002/cncr.23844
  3. Botha JL, Bray F, Sankila R, Parkin DM (2003). Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer, 39, 1718-29. https://doi.org/10.1016/S0959-8049(03)00118-7
  4. Cabanes A, Vidal E, Perez-Gomez B, et al (2009). Age-specific breast, uterine and ovarian cancer mortality trends in Spain: changes from 1980 to 2006. Cancer Epidemiol, 33, 169-75. https://doi.org/10.1016/j.canep.2009.08.010
  5. Chavarri-Guerra Y, Villarreal-Garza C, Liedke P, et al (2012). Breast cancer in Mexico: a growing challenge to health and the health system. Lancet Oncol, 13, 335-46. https://doi.org/10.1016/S1470-2045(12)70246-2
  6. Freitas-Junior R, Gonzaga CM, Freitas NM, et al (2012). Disparities in female breast cancer mortality rates in Brazil between 1980 and 2009. Clinics, 67, 731-7. https://doi.org/10.6061/clinics/2012(07)05
  7. Gonzalez de Cossio T, Escobar-Zaragoza L, Gonzalez-Castell D, et al (2013). Breastfeeding in Mexico was stable, on average, but deteriorated among the poor, whereas complementary feeding improved: results from the 1999 to 2006 National Health and Nutrition Surveys. J Nutrition, 143, 664-671. https://doi.org/10.3945/jn.112.163097
  8. Gonzalez-Robledo MC, Gonzalez-Robledo LM, Nigenda G (2013). Public policy-making on breast cancer in Latin America. Rev Panam Salud Publica, 33, 183-9. https://doi.org/10.1590/S1020-49892013000300004
  9. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA: Cancer J Clin, 6, 69-90.
  10. Jimenez-Cruz A, de Escobar-Aznar YM, Castillo-Ruiz O, et al (2012). Beliefs about causes and consequences of obesity among women in two Mexican cities. J Health Popul Nutr, 30, 311-6.
  11. Ki-Bong Y, Jeoung A Kwon, Eun Cho, et al (2013). Is mammography for breast cancer screening cost-effective in both western and Asian countries?: Results of a systematic review. Asian Pac J Cancer Prev, 14, 4141-9. https://doi.org/10.7314/APJCP.2013.14.7.4141
  12. Kyu-Won J, Young-Joo W, Hyun-Joo K, et al (2013). Cancer Statistics in Korea: Incidence, Mortality, Survival and Prevalence in 2010. Cancer Res Treat, 45, 1-14. https://doi.org/10.4143/crt.2013.45.1.1
  13. Leong SP, Shen ZZ, Liu TJ, et al (2010). Is breast cancer the same disease in Asian and Western countries? World J Surg, 34, 2308-24. https://doi.org/10.1007/s00268-010-0683-1
  14. Martinez-Montanez OG, Uribe-Zuniga P, Hernandez-Avila M (2009). Public policies for the detection of breast cancer in Mexico. Salud Publica de Mexico, 51, 350-60. https://doi.org/10.1590/S0036-36342009000800028
  15. Pedraza AM, Pollan M, Pastor-Barriuso R, Cabanes A (2012). Disparities in breast cancer mortality trends in a middle income country, Breast Cancer Res Treat, 134, 1199-207. https://doi.org/10.1007/s10549-012-2026-4
  16. Pollan M, Pastor-Barriuso R, Ardanaz E, et al (2009). Recent changes in breast cancer incidence in Spain, 1980-2004. J Natl Cancer Inst, 101, 1584-91. https://doi.org/10.1093/jnci/djp358
  17. Santos Sda S, Melo LR, Koifman RJ, Koifman S. (2013). Breast cancer incidence and mortality in women under 50 years of age in Brazil. Cad Saude Publica, 29, 2230-40. https://doi.org/10.1590/0102-311x00030713
  18. Shaukat U, Muhammad I, Mehmood N (2013). Epidemiology, major risk factors and genetic predisposition for breast cancer in the Pakistani population. Asian Pac J Cancer Prev, 14, 5625-9. https://doi.org/10.7314/APJCP.2013.14.10.5625
  19. Sipetic-Grujicic S, Murtezani Z, Ratkov I, et al (2013). Comparison of male and female breast cancer incidence and mortality trends in Central Serbia. Asian Pac J Cancer Prev, 14, 5681-5. https://doi.org/10.7314/APJCP.2013.14.10.5681
  20. Taghavi Afsoon, Zeinab Fazeli, Mohsen Vahedi, et al (2012). Increased Trend of Breast Cancer Mortality in Iran. Asian Pac J Cancer Prev, 13, 367-370. https://doi.org/10.7314/APJCP.2012.13.1.367

Cited by

  1. Diagnostic Classification Scheme in Iranian Breast Cancer Patients using a Decision Tree vol.15, pp.14, 2014, https://doi.org/10.7314/APJCP.2014.15.14.5593
  2. Relation of Alcohol/Tobacco use with Metastasis, Hormonal (Estrogen and Progesterone) Receptor Status and c-erbB2 Protein in Mammary Ductal Carcinoma vol.15, pp.14, 2014, https://doi.org/10.7314/APJCP.2014.15.14.5709
  3. Long-Term Survival of Women with Locally Advanced Breast Cancer with ≥10 Involved Lymph Nodes at Diagnosis vol.15, pp.8, 2014, https://doi.org/10.7314/APJCP.2014.15.8.3435
  4. Lack of Efficacy of Tai Chi in Improving Quality of Life in Breast Cancer Survivors: a Systematic Review and Meta-analysis vol.15, pp.8, 2014, https://doi.org/10.7314/APJCP.2014.15.8.3715
  5. Innovation Status of Gene Therapy for Breast Cancer vol.16, pp.9, 2015, https://doi.org/10.7314/APJCP.2015.16.9.4133
  6. Association of Histopathological Markers with Clinico-Pathological Factors in Mexican Women with Breast Cancer vol.16, pp.18, 2016, https://doi.org/10.7314/APJCP.2015.16.18.8397
  7. Neural Transdifferentiation: MAPTau Gene Expression in Breast Cancer Cells vol.17, pp.4, 2016, https://doi.org/10.7314/APJCP.2016.17.4.1967
  8. Cancer mortality predictions for 2017 in Latin America vol.28, pp.9, 2017, https://doi.org/10.1093/annonc/mdx301
  9. Alternative Splicing in Breast Cancer and the Potential Development of Therapeutic Tools vol.8, pp.10, 2017, https://doi.org/10.3390/genes8100217
  10. Delays in Breast Cancer Detection and Treatment in Developing Countries vol.12, pp.1178-2234, 2018, https://doi.org/10.1177/1178223417752677
  11. Extracts Have Cytotoxic and Migration-Inhibitory Effects in Breast Cancer Cell Lines vol.17, pp.3, 2018, https://doi.org/10.1177/1534735418766416